Kathryn Falberg has served as Senior Vice President and Chief Financial Officer of Jazz Pharmaceuticals since December 2009. From 1995 through 2001, Ms. Falberg was with Amgen, Inc., where she served as Senior Vice President Finance, Strategy and Chief Financial Officer, and before that as Vice President, Controller and Chief Accounting Officer, and Vice President, Treasurer. From 2001 to 2009, Ms. Falberg worked with a number of smaller companies while also serving as a corporate director and audit committee chair for several companies. Ms. Falberg received an M.B.A and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant. Ms. Falberg currently serves on the Board, and is Chair of the Audit Committee, of biopharmaceutical company QLT, Inc.